Stryker | SYK - Selling And Administration Expenses

Stock Price
327.51
Daily Change
-2.14 -0.65%
Monthly
-0.04%
Yearly
-10.29%
Q2 Forecast
335.77

Stryker reported $2.14B in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.27B 138M Mar/2026
AtriCure USD 78.34M 109K Dec/2025
Avanos Medical USD 78.8M 1.2M Dec/2025
Baxter International USD 761M 53M Dec/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Boston Scientific USD 1.83B 93M Dec/2025
CONMED USD 166.76M 26.42M Dec/2025
Cooper Companies USD 373.1M 46.1M Dec/2025
Danaher USD 1.86B 166M Mar/2026
Dexcom USD 299.9M 31.5M Dec/2025
Edwards Lifesciences USD 522.2M 80.7M Mar/2026
Globus Medical USD 318.48M 4.88M Dec/2025
Haemonetics USD 109.15M 7.54M Dec/2025
Insulet USD 331.4M 16.2M Dec/2025
Integra LifeSciences USD 156.45M 12.6M Dec/2025
Intuitive Surgical USD 613.3M 73.8M Mar/2026
J&J USD 6.03B 719M Mar/2026
Masimo USD 128M 11.6M Dec/2025
Medtronic 2.97B 159M Sep/2025
Merit Medical Systems USD 114.83M 7.45M Dec/2025
Olympus JPY 125.65B 5.75B Dec/2025
Smith & Nephew USD 1.42B 65M Dec/2025
Steris USD 352.3M 2.6M Dec/2025
Stryker USD 2.14B 150M Dec/2025
Tandem Diabetes Care USD 99.86M 5.34M Dec/2025
Teleflex USD 222.37M 59.4M Dec/2025
Terumo JPY 105.26B 7.38B Dec/2025
Zimmer Biomet Holdings USD 855.7M 44.3M Dec/2025